Nichi-Iko Pharmaceutical Co.
Nichi-Iko Pharmaceutical Co. Technographics
Nichi-Iko Pharmaceutical Co. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Nichi-Iko Pharmaceutical Co. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 2656 Nichi-Iko Pharmaceutical Co. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Nichi-Iko Pharmaceutical Co. has purchased the following applications: GLOVIA G2 for Manufacturing ERP in 2019, Microsoft 365 for Collaboration in 2017, Google Analytics 360 for Marketing Analytics in 2018 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Nichi-Iko Pharmaceutical Co. is running and its propensity to invest more and deepen its relationship with FUJITSU GLOVIA , Microsoft , Google or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Nichi-Iko Pharmaceutical Co. revenues, which have grown to $1.60 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Nichi-Iko Pharmaceutical Co. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Nichi-Iko Pharmaceutical Co. Tech Stack and Enterprise Applications
Nichi-Iko Pharmaceutical Co. ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| FUJITSU GLOVIA | Legacy | GLOVIA G2 | Manufacturing ERP | ERP Services and Operations | n/a | 2019 | 2019 |
In 2019, Nichi-Iko Pharmaceutical Co. implemented GLOVIA G2 as its Manufacturing ERP to standardize finance, accounting and procurement operations at the Nichi-Iko Gifu plant. The GLOVIA G2 deployment is explicitly tied to financial analysis and accounting use cases, and to procurement workflow redesign following an operational transfer from Teva Pharmaceuticals to Nichi-Iko.
The implementation configured core financial analysis and accounting capabilities within GLOVIA G2, including budget planning and quarterly adjustment reporting, purchase price variance tracking, and conversion cost variance summarization. GLOVIA G2 was used to host redesigned purchase order and payment request forms, and to instrument payment team operations and cash management processes, aligning transactional configuration with the company accounting rules and audit requirements.
Integrations were implemented to synchronize external procurement platforms e-labo and Biznet with the fundamental accounting system Glovia, enabling automated transfer of purchase order and payment request data into GLOVIA G2. The project also included adjustments to SAP for accurate cost allocation where SAP remained in scope for certain cost accounting processes, and integration points covered bank transfer processing and electronic tax filing workflows.
Governance and rollout focused on process redesign and operational handover, with new purchase and payment flows engineered and launched, negotiation of vendor payment terms incorporated into system workflows, and documentation prepared for external audit management. The narrative centers on GLOVIA G2 as the Manufacturing ERP supporting finance, accounting and procurement business functions at Nichi-Iko Pharmaceutical Co.
|
Nichi-Iko Pharmaceutical Co. Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2017 | 2017 |
In 2017, Nichi-Iko Pharmaceutical Co. implemented Microsoft 365 as a Collaboration platform. Public information on the company website indicates Microsoft 365 is in use on their site, and the deployment positioned Microsoft 365 to support corporate communications and document collaboration across the organization.
The implementation leverages Microsoft 365 core capabilities aligned to the Collaboration category, including Exchange Online for email, SharePoint Online for intranet and document management, Teams for real-time collaboration, OneDrive for file sync, and Office productivity applications. Operational scope centers on corporate communications, knowledge management, regulatory document collaboration, and cross-departmental project workflows within the companys Japan operations, with governance practices aligned to the platform such as centralized identity and access controls, content lifecycle policies, and document versioning to support compliance and auditability.
|
Nichi-Iko Pharmaceutical Co. CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Legacy | Google Analytics 360 | Marketing Analytics | CRM | n/a | 2018 | 2018 |
In 2018, Nichi-Iko Pharmaceutical Co. deployed Google Analytics 360 on its public website, instrumenting the site's measurement layer via the analytics.js loader referenced in company resources at http://nichiiko-ir.irbridge.com/resources/sw_js/analytics.js. The deployment established Google Analytics 360 as the primary Marketing Analytics platform for web behavior collection and centralized reporting.
The implementation focused on core Google Analytics 360 capabilities including pageview and event measurement, property and view structuring for segmented reporting, and the use of custom dimensions and metrics to capture product and campaign attributes for marketing analysis. Configuration work included tag-level control, sessionization rules, and advanced segmentation to support cohort analysis and channel attribution workflows consistent with Marketing Analytics best practices.
Operational ownership encompassed marketing, digital analytics, and web operations teams, with governance defined through measurement standards, data access controls, and a reporting cadence to support campaign performance and corporate analytics needs. Tagging standards and data governance were instituted to ensure measurement consistency across the website, aligning Google Analytics 360 with the companys marketing analytics processes.
|
|
 |
|
|
Tag Management | CRM |
|
2018 | 2018 |
|
Nichi-Iko Pharmaceutical Co. IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2017 | 2017 |
|
Nichi-Iko Pharmaceutical Co. CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2018 | 2018 |
|
IT Decision Makers and Key Stakeholders at Nichi-Iko Pharmaceutical Co.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Nichi-Iko Pharmaceutical Co. Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Nichi-Iko Pharmaceutical Co. IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Nichi-Iko Pharmaceutical Co. digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Nichi-Iko Pharmaceutical Co. Technographics
Nichi-Iko Pharmaceutical Co. is a Life Sciences organization based in Japan,
with around 2656 employees and annual revenues of $1.60 billion.
Nichi-Iko Pharmaceutical Co. operates a diverse technology stack with applications such as
GLOVIA G2, Microsoft 365 and Google Analytics 360,
covering areas like Manufacturing ERP, Collaboration and Marketing Analytics.
Nichi-Iko Pharmaceutical Co. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as FUJITSU GLOVIA, Microsoft and Google.
Nichi-Iko Pharmaceutical Co. recently adopted applications including
GLOVIA G2 in 2019, Google Analytics 360 in 2018 and Google Tag Manager in 2018,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Nichi-Iko Pharmaceutical Co.’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Nichi-Iko Pharmaceutical Co.’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Nichi-Iko Pharmaceutical Co. technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.